Active Ingredient(s): Liothyronine
FDA Approved: * December 31, 1991
Pharm Company: * JONES PHARMA
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Triostat Overview

Liothyronine is a manufactured form of the thyroid hormone triiodothyronine (T3).[1] It is most commonly used to treat hypothyroidism and myxedema coma.[1] It can be taken by mouth or by injection into a vein.[1] Side effects may occur from excessive doses.[1] This may include weight loss, fever, headache, anxiety, trouble sleeping, arrythmias, and heart failure.[1] Use in pregnancy and breastfeeding is generally ...

Read more Triostat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Triostat Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 0.01mg/ml, 10mcg/ml
  • Tablet: 0.005mg, 0.025mg, 0.05mg, 25mcg, 50mcg, 5mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Triostat: (1 result)

Sorted by National Drug Code
  • 42023-120 Triostat 10 ug/ml Intravenous Injection by Jhp Pharmaceuticals LLC

Other drugs which contain Liothyronine or a similar ingredient: (2 results)